BOULDER, Colo.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CLVS&src=ctag" target="_blank"gt;$CLVSlt;/agt;–Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter
2019 financial results on Tuesday, May 7, 2019, before the open of the
U.S. financial markets. Clovis’ senior management will host a conference
call and live audio webcast at 8:30 a.m. ET to discuss the company’s
results in greater detail.
The conference call is being webcast and can be accessed from the Clovis
Oncology website at www.clovisoncology.com.
A replay of the webcast will be available for 30 days.
Conference Call Details
Clovis will hold a conference call to discuss first quarter 2019 results
on Tuesday, May 7, at 8:30 a.m. ET. The conference call will be
simultaneously webcast on the Company’s web site at www.clovisoncology.com,
and archived for future review. Dial-in numbers for the conference call
are as follows: US participants 877.698.7048, International participants
647.689.5448, conference ID: 8567356.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer agents
in the U.S., Europe and additional international markets. Clovis
Oncology targets development programs at specific subsets of cancer
populations, and simultaneously develops, with partners, diagnostic
tools intended to direct a compound in development to the population
that is most likely to benefit from its use. Clovis Oncology is
headquartered in Boulder, Colorado; please visit www.clovisoncology.com
for more information, including additional office locations in the U.S.
Clovis Investor Contacts:
Anna Sussman, 303.625.5022